1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Alopecia Areata: Epidemiology Forecast to 2028

Alopecia Areata: Epidemiology Forecast to 2028

  • July 2019
  • 31 pages
  • ID: 5816844
  • Format: PDF
  • By GlobalData

Summary

Table of Contents

Search Inside

Alopecia Areata: Epidemiology Forecast to 2028

Summary
Alopecia areata (AA) is a common, clinically heterogeneous, immune-mediated and a non-scarring hair loss disorder (Hordinsky, 2013).It typically presents with sharply demarcated round patches of hair loss and may present at any age.

Experimental and clinical evidence suggests that AA is caused by autoimmune attack against the hair follicles. The precise path mechanism, however, remains unknown (Dainichi and Kabashima, 2017).

Epidemiologists utilized national databases and robust peer-reviewed journal articles to build the forecast for the diagnosed incident and prevalent cases of AA in the 7MM. Epidemiologists applied country-specific incidence and prevalence rates of AA, wherever available, to each country’s population to obtain the number of estimated diagnosed incident cases and lifetime diagnosed prevalent cases respectively.

The following data describes epidemiology of AA. Epidemiologists forecast an increase in the diagnosed incident cases of AA in the 7MM from 156,056 diagnosed incident cases in 2018 to 157,883 diagnosed incident cases in 2028, with an Annual Growth Rate (AGR) of 0.12% during the forecast period. The US will have the highest number of diagnosed incident cases of AA among the 7MM, while Spain will have the lowest. Epidemiologists forecast an increase in the lifetime diagnosed prevalent cases of AA in the 7MM from 6,388,360 lifetime diagnosed prevalent cases in 2018 to 6,473,746 lifetime diagnosed prevalent cases in 2028, with an AGR of 0.13% during the forecast period. US will have the highest number of lifetime diagnosed prevalent cases of AA among the 7MM, while Spain will have the lowest.

Scope
- The Alopecia Areata Epidemiology Report and Model provide an overview of the risk factors and global trends of Alopecia Areata (AA) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan).
- The report includes a 10-year epidemiological forecast for the diagnosed incident cases and lifetime diagnosed prevalent cases of AA segmented by sex, and age (for all ages) in these markets. The diagnosed incident and lifetime diagnosed prevalent cases of AA are further segmented by severity (mild, moderate, and severe). Additionally, the model includes a 10-year epidemiological forecast for the 12-months diagnosed prevalent cases of AA.
- The AA epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
- The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy
The AA Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global AA market.
- Quantify patient populations in the global AA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AA therapeutics in each of the markets covered.
- Understand magnitude of AA population by severity.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
25% Off

($3995)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Axial Spondyloarthritis - Epidemiology Forecast to 2028

Axial Spondyloarthritis - Epidemiology Forecast to 2028

  • $ 3995
  • September 2019

Axial Spondyloarthritis - Epidemiology Forecast to 2028SummaryAxial spondyloarthritis (AxSpA) is a condition characterized by predominant inflammation in the spine and/or sacroiliac joints, with inflammatory ...

Ischemia Reperfusion Injury - Pipeline Review, H2 2019

Ischemia Reperfusion Injury - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Ischemia Reperfusion Injury - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury - Pipeline Review, H2 2019, provides an overview of the Ischemia ...

Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019

Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019’; Nuclear Receptor ROR Gamma (Nuclear Recepto ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on